Home › Funds › DGS Capital Management, LLC › GSK

DGS Capital Management, LLC position in GSK

GSK PLC ADR F · Health Care

DGS Capital Management, LLC reported holding 42,695 shares of GSK (GSK PLC ADR F) in its Q1 2026 13F filing — a position valued at US$2.4M, representing 0.41% of its reported portfolio and ranking #40 among its reported holdings. DGS Capital Management, LLC has disclosed GSK holdings in 10 of the last 11 reported quarters, going back to Q3 2023.

Latest position (Q1 2026)42.70K sh
Reported value held$2.36M
Portfolio Weight0.41%
First reportedQ3 2023
Last changeAdd
Updated2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

How DGS Capital Management, LLC's GSK position evolved

DGS Capital Management, LLC first disclosed a stake in GSK in Q3 2023 at 37,463 shares (US$1.4M). The position peaked in Q1 2026 at 42,695 shares, worth US$2.4M. Across 10 filings, DGS Capital Management, LLC increased the stake 7 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q1 2026) shows 42,695 shares valued at US$2.4M — an increase of 2,761 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 37.46K $1.36M New
Q4 2023 30.23K $1.12M Reduce
Q1 2024 30.69K $1.32M Add
Q3 2024 34.44K $1.41M Add
Q4 2024 28.27K $956.02K Reduce
Q1 2025 29.13K $1.13M Add
Q2 2025 32.56K $1.25M Add
Q3 2025 36.34K $1.57M Add
Q4 2025 39.93K $1.96M Add
Q1 2026 42.70K $2.36M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GSK and 13F data

GSK (GSK PLC ADR F) is a Health Care company. 23 other funds we track also report a position in GSK — the largest reported positions include Dodge & Cox (US$2.53B), DODGE & COX (US$2.53B), PRIMECAP MANAGEMENT CO/CA/ (US$1.32B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GSK

All GSK fund holders →

FAQ

How long has DGS Capital Management, LLC held GSK?

DGS Capital Management, LLC has disclosed GSK holdings in 10 of the last 11 reported quarters, going back to Q3 2023.

What is DGS Capital Management, LLC's current position in GSK?

As of Q1 2026, DGS Capital Management, LLC holds 42.70K shares of GSK (GSK PLC ADR F), valued at $2.36M, representing 0.41% of its reported portfolio and ranking #40.

Has DGS Capital Management, LLC been buying or selling GSK?

In the latest 13F filing (Q1 2026), DGS Capital Management, LLC increased its position in GSK. The position peaked in Q1 2026 at 42.70K shares.

Which other funds hold GSK?

Other major institutional holders of GSK include Dodge & Cox, DODGE & COX, PRIMECAP MANAGEMENT CO/CA/, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.